Continue to site >
Trending ETFs

Franklin Genomic Advancements ETF

Active ETF
HELX
Payout Change
Pending
Price as of:
$32.45 +0.41 +1.28%
primary theme
Health Care Sector Equity
HELX (ETF)

Franklin Genomic Advancements ETF

Payout Change
Pending
Price as of:
$32.45 +0.41 +1.28%
primary theme
Health Care Sector Equity
HELX (ETF)

Franklin Genomic Advancements ETF

Payout Change
Pending
Price as of:
$32.45 +0.41 +1.28%
primary theme
Health Care Sector Equity

Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$32.45

$11.7 M

0.01%

$0.00

0.50%

Vitals

YTD Return

-25.0%

1 yr return

-23.4%

3 Yr Avg Return

N/A

5 Yr Avg Return

N/A

Net Assets

$11.7 M

Holdings in Top 10

43.2%

52 WEEK LOW AND HIGH

$32.0
$29.72
$58.23

Expenses

OPERATING FEES

Expense Ratio 0.50%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 61.43%

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund

Investment Style

Health


Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$32.45

$11.7 M

0.01%

$0.00

0.50%

HELX - Profile

Distributions

  • YTD Total Return -33.1%
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio -0.32%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    Franklin Genomic Advancements ETF
  • Fund Family Name
    Franklin Templeton Investments
  • Inception Date
    Feb 25, 2020
  • Shares Outstanding
    349986
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Joyce Lin

Fund Description

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.


HELX - Performance

Return Ranking - Trailing

Period HELX Return Category Return Low Category Return High Rank in Category (%)
YTD -25.0% -40.8% 25.3% 93.62%
1 Yr -23.4% -60.2% 11.7% 85.38%
3 Yr N/A* -10.0% 19.7% N/A
5 Yr N/A* -6.4% 16.9% N/A
10 Yr N/A* 6.4% 18.5% N/A

* Annualized

Return Ranking - Calendar

Period HELX Return Category Return Low Category Return High Rank in Category (%)
2021 9.5% -79.9% 24.2% 22.81%
2020 N/A -13.6% 178.2% N/A
2019 N/A 3.8% 63.8% N/A
2018 N/A -49.7% 21.5% N/A
2017 N/A -59.8% 54.4% N/A

Total Return Ranking - Trailing

Period HELX Return Category Return Low Category Return High Rank in Category (%)
YTD -33.1% -46.5% 25.3% 95.21%
1 Yr -23.4% -60.2% 28.3% 84.13%
3 Yr N/A* -13.2% 20.0% N/A
5 Yr N/A* -6.4% 16.9% N/A
10 Yr N/A* 6.4% 18.5% N/A

* Annualized

Total Return Ranking - Calendar

Period HELX Return Category Return Low Category Return High Rank in Category (%)
2021 9.5% -79.9% 24.2% 22.81%
2020 N/A -13.6% 178.2% N/A
2019 N/A 3.8% 63.8% N/A
2018 N/A -49.7% 22.2% N/A
2017 N/A -59.8% 54.4% N/A

HELX - Holdings

Concentration Analysis

HELX Category Low Category High HELX % Rank
Net Assets 11.7 M 732 K 46.2 B 85.64%
Number of Holdings 52 21 473 69.90%
Net Assets in Top 10 5.04 M 2.18 K 21.6 B 78.64%
Weighting of Top 10 43.18% 12.3% 80.8% 56.31%

Top 10 Holdings

  1. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 7.15%
  2. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 7.15%
  3. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 7.15%
  4. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 7.15%
  5. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 7.15%
  6. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 7.15%
  7. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 7.15%
  8. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 7.15%
  9. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 7.15%
  10. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 7.15%

Asset Allocation

Weighting Return Low Return High HELX % Rank
Stocks
97.47% 85.37% 106.13% 75.24%
Cash
2.53% -0.10% 9.01% 17.96%
Preferred Stocks
0.00% 0.00% 7.86% 82.04%
Other
0.00% -22.99% 3.38% 80.58%
Convertible Bonds
0.00% 0.00% 0.37% 83.50%
Bonds
0.00% 0.00% 12.39% 81.55%

Stock Sector Breakdown

Weighting Return Low Return High HELX % Rank
Healthcare
89.08% 59.26% 100.00% 98.06%
Basic Materials
7.16% 0.00% 14.83% 0.97%
Real Estate
2.34% 0.00% 7.13% 4.37%
Technology
1.42% 0.00% 22.69% 3.40%
Utilities
0.00% 0.00% 0.00% 81.55%
Industrials
0.00% 0.00% 7.02% 83.01%
Financial Services
0.00% 0.00% 1.85% 85.44%
Energy
0.00% 0.00% 0.00% 81.55%
Communication Services
0.00% 0.00% 9.11% 83.50%
Consumer Defense
0.00% 0.00% 25.73% 83.50%
Consumer Cyclical
0.00% 0.00% 14.20% 82.04%

Stock Geographic Breakdown

Weighting Return Low Return High HELX % Rank
US
75.60% 53.67% 104.41% 81.07%
Non US
21.87% 0.00% 45.40% 21.84%

HELX - Expenses

Operational Fees

HELX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.50% 0.08% 3.13% 75.12%
Management Fee 0.50% 0.00% 1.25% 20.21%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

HELX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

HELX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

HELX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 61.43% 0.00% 238.00% 77.33%

HELX - Distributions

Dividend Yield Analysis

HELX Category Low Category High HELX % Rank
Dividend Yield 0.01% 0.00% 9.37% 16.59%

Dividend Distribution Analysis

HELX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Monthly Semi-Annually

Net Income Ratio Analysis

HELX Category Low Category High HELX % Rank
Net Income Ratio -0.32% -2.54% 1.92% 60.69%

Capital Gain Distribution Analysis

HELX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Semi-Annually Annually

Dividend Payout History

View More +

HELX - Fund Manager Analysis

Managers

Joyce Lin


Start Date

Tenure

Tenure Rank

Feb 25, 2020

2.26

2.3%

Ms. Lin has been a portfolio manager of Franklin Tenmpleton, providing research and advice on the purchases and sales of individual securities, and portfolio risk assessment. She joined Franklin Templeton in 2014. Prior to joining Franklin Templeton in 2014, Ms. Lin was a research associate at Cooke & Bieler, a value based investment management firm.

Matthew Moberg


Start Date

Tenure

Tenure Rank

Feb 25, 2020

2.26

2.3%

Moberg is a Vice President, Portfolio Manager and Research Analyst of Franklin Advisers, Inc. He provides research and advice on the purchases and sales of individual securities, and portfolio risk assessment. He joined Franklin Templeton Investments in 1998. Moberg holds the Certified Public Accountant designation. Mr. Moberg earned his B.A. in history from Washington and Lee University and an M.B.A. with distinction from the University of Michigan.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.54 2.12